Literature DB >> 2664125

Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery.

V Srinivasan1, W I Higuchi, S M Sims, A H Ghanem, C R Behl.   

Abstract

Three factors are of primary importance in determining the iontophoretic flux of a charged solute: the electrochemical potential gradient across the skin, an increase in skin permeability to passive transport due to iontophoresis (loosely defined as skin damage), and a current-induced water flux. The latter two factors can also affect the transport of uncharged solutes during iontophoresis. A method of correcting for the skin damage effect is introduced. The contributions of the water transport effect relative to that of the applied voltage drop for charged solutes is estimated. It is shown that the water transport contribution is generally lower than the contribution due to the applied voltage drop. The observed iontophonetic flux of the enhancement factors due to the applied voltage drop alone are compared with the theoretical predictions based on the constant field assumption. It is shown that the theoretical predictions are higher than the experimental observations. This work also examines, for the first time, a synergism of iontophoresis and pretreatment with a chemical penetration enhancer as a means for delivering high molecular weight polypeptides. It is shown that a 2-h pretreatment with absolute ethanol followed by iontophoresis dramatically increases the permeability coefficient of insulin through human skin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664125     DOI: 10.1002/jps.2600780506

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

Review 1.  Synergistic effect of enhancers for transdermal drug delivery.

Authors:  S Mitragotri
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Skin alteration and convective solvent flow effects during iontophoresis. II. Monovalent anion and cation transport across human skin.

Authors:  S M Sims; W I Higuchi; V Srinivasan
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

3.  Percutaneous absorption enhancement of leuprolide.

Authors:  M Y Lu; D Lee; G S Rao
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

Review 4.  Improvement of drug absorption through enhancers.

Authors:  A G de Boer; E J van Hoogdalem; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 5.  Transport of peptide and protein drugs across biological membranes.

Authors:  J C Verhoef; H E Boddé; A G de Boer; J A Bouwstra; H E Junginger; F W Merkus; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

6.  Study of the mechanisms of flux enhancement through hairless mouse skin by pulsed DC iontophoresis.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

7.  Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.

Authors:  Katarzyna Migalska; Desmond I J Morrow; Martin J Garland; Raj Thakur; A David Woolfson; Ryan F Donnelly
Journal:  Pharm Res       Date:  2011-03-25       Impact factor: 4.200

Review 8.  Electrically-assisted transdermal drug delivery.

Authors:  J E Riviere; M C Heit
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

9.  Electrochemical characterization of human skin by impedance spectroscopy: the effect of penetration enhancers.

Authors:  K Kontturi; L Murtomäki; J Hirvonen; P Paronen; A Urtti
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

10.  Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro.

Authors:  D B Bommannan; J Tamada; L Leung; R O Potts
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.